| Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality D Costa, B Simbrunner, M Jachs, L Hartl, D Bauer, R Paternostro, ... Journal of Hepatology 74 (4), 819-828, 2021 | 116 | 2021 |
| Gut-liver axis signaling in portal hypertension B Simbrunner, M Mandorfer, M Trauner, T Reiberger World journal of gastroenterology 25 (39), 5897, 2019 | 82 | 2019 |
| HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease G Semmler, EL Meyer, K Kozbial, P Schwabl, S Hametner-Schreil, ... Journal of hepatology 76 (4), 812-821, 2022 | 70 | 2022 |
| Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease B Scheiner, G Semmler, F Maurer, P Schwabl, TA Bucsics, R Paternostro, ... Liver International 40 (1), 194-204, 2020 | 65 | 2020 |
| Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes M Jachs, L Hartl, D Schaufler, C Desbalmes, B Simbrunner, E Eigenbauer, ... Gut 70 (9), 1758-1767, 2021 | 59 | 2021 |
| Does the functional liver imaging score derived from gadoxetic acid–enhanced MRI predict outcomes in chronic liver disease? N Bastati, L Beer, M Mandorfer, S Poetter-Lang, D Tamandl, Y Bican, ... Radiology 294 (1), 98-107, 2020 | 58 | 2020 |
| Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease L Hartl, K Haslinger, M Angerer, G Semmler, M Schneeweiss‐Gleixner, ... Hepatology 76 (6), 1563-1575, 2022 | 55 | 2022 |
| Noninvasive risk stratification after HCV eradication in patients with advanced chronic liver disease G Semmler, T Binter, K Kozbial, P Schwabl, S Hametner‐Schreil, ... Hepatology 73 (4), 1275-1289, 2021 | 55 | 2021 |
| Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease J Trebicka, W Gu, V de Ledinghen, C Aubé, A Krag, M Praktiknjo, ... Gut 71 (2), 402-414, 2022 | 54 | 2022 |
| therapeutic aspects of bile acid signalling in the gut‐liver axis B Simbrunner, M Trauner, T Reiberger Alimentary Pharmacology & Therapeutics 54 (10), 1243-1262, 2021 | 48 | 2021 |
| A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter F Koban, A El-Kasaby, C Häusler, T Stockner, BM Simbrunner, HH Sitte, ... Journal of Biological Chemistry 290 (21), 13263-13278, 2015 | 48 | 2015 |
| Clinical course of porto-sinusoidal vascular disease is distinct from idiopathic noncirrhotic portal hypertension K Wöran, G Semmler, M Jachs, B Simbrunner, DJM Bauer, T Binter, ... Clinical Gastroenterology and Hepatology 20 (2), e251-e266, 2022 | 45 | 2022 |
| Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, B Scheiner, ... Clinical Gastroenterology and Hepatology 20 (6), 1362-1373. e6, 2022 | 42 | 2022 |
| Safety of direct oral anticoagulants in patients with advanced liver disease G Semmler, K Pomej, DJM Bauer, L Balcar, B Simbrunner, T Binter, ... Liver International 41 (9), 2159-2170, 2021 | 42 | 2021 |
| Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, L Balcar, B Hofer, ... Clinical Gastroenterology and Hepatology 21 (9), 2318-2326. e7, 2023 | 38 | 2023 |
| Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis G Semmler, K Wöran, B Scheiner, LW Unger, R Paternostro, J Stift, ... United European gastroenterology journal 8 (3), 321-331, 2020 | 38 | 2020 |
| Portal hypertensive gastropathy is associated with iron deficiency anemia B Simbrunner, A Beer, K Wöran, F Schmitz, C Primas, M Wewalka, ... Wiener klinische Wochenschrift 132, 1-11, 2020 | 37 | 2020 |
| Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD B Scheiner, L Balcar, RJ Nussbaumer, J Weinzierl, R Paternostro, ... Journal of hepatology 76 (5), 1090-1099, 2022 | 35 | 2022 |
| Prevention of first decompensation in advanced chronic liver disease M Mandorfer, B Simbrunner Clinics in liver disease 25 (2), 291-310, 2021 | 34 | 2021 |
| MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease L Beer, N Bastati, A Ba‐Ssalamah, S Pötter‐Lang, K Lampichler, Y Bican, ... Liver International 40 (11), 2797-2807, 2020 | 34 | 2020 |
